Journal of Proteomics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058672, encodeId=c59d10586e25f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiweizhe, createdTime=Fri Oct 08 17:52:50 CST 2021, time=2021-10-08, status=1, ipAttribution=)]

2022-08-15 不懂科研的科研狗子

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：蛋白质组学
经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？

51 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058672, encodeId=c59d10586e25f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiweizhe, createdTime=Fri Oct 08 17:52:50 CST 2021, time=2021-10-08, status=1, ipAttribution=)]

2021-10-08 nihao_aiwenzhe

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：临床蛋白组学;蛋白组学;质谱
经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept

84 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058672, encodeId=c59d10586e25f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiweizhe, createdTime=Fri Oct 08 17:52:50 CST 2021, time=2021-10-08, status=1, ipAttribution=)]

2021-12-15 ms1000001868448704

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：蛋白组学
经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。

70 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058672, encodeId=c59d10586e25f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiweizhe, createdTime=Fri Oct 08 17:52:50 CST 2021, time=2021-10-08, status=1, ipAttribution=)]

2023-07-16 ms4000001156703951 来自河南省

Submitted to Journal状态5天了还没到编辑手里这个正常吗

42 0

[GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058672, encodeId=c59d10586e25f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiweizhe, createdTime=Fri Oct 08 17:52:50 CST 2021, time=2021-10-08, status=1, ipAttribution=)]

2020-03-31 ILVhera

审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况

211 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058672, encodeId=c59d10586e25f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiweizhe, createdTime=Fri Oct 08 17:52:50 CST 2021, time=2021-10-08, status=1, ipAttribution=)]

2017-09-18 LhtFantasy

想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!

479 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058672, encodeId=c59d10586e25f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiweizhe, createdTime=Fri Oct 08 17:52:50 CST 2021, time=2021-10-08, status=1, ipAttribution=)]

2017-10-04 奋斗党

是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表:
从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???

186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???

382 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058672, encodeId=c59d10586e25f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiweizhe, createdTime=Fri Oct 08 17:52:50 CST 2021, time=2021-10-08, status=1, ipAttribution=)]

2021-12-29 MS54455111222

一般期刊要求关键词有多少个？

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058672, encodeId=c59d10586e25f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiweizhe, createdTime=Fri Oct 08 17:52:50 CST 2021, time=2021-10-08, status=1, ipAttribution=)]

2021-12-27 MS54455111222

关键词最少几个？

73 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058672, encodeId=c59d10586e25f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiweizhe, createdTime=Fri Oct 08 17:52:50 CST 2021, time=2021-10-08, status=1, ipAttribution=)]

2021-10-08 nihao_aiweizhe

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：蛋白组学;质谱
经验分享：2020-10-11 Submitted to Journal
2020-10-11 With Editor
2020-10-31 Under Review
2020-12-07 Decision in Process
2020-12-12 Minor Revision
2021-1-5 Revision Submitted to Journal
2021-1-16 Under Review
2021-4-21 Accept

71 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务